SU-DHL-1 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | SU-DHL-1 is a human anaplastic large cell lymphoma (ALCL) cell line established from the pleural effusion of a child diagnosed with diffuse histiocytic lymphoma. It was one of the first human lymphoma lines established in continuous culture and has been rigorously characterized both phenotypically and genetically. Morphologically, SU-DHL-1 retains features of the primary tumor, including large cytoplasmic vacuoles, which are lipid-containing. Histochemical studies show activity of nonspecific esterase and acid phosphatase. Unlike lymphoblastoid cell lines, SU-DHL-1 is negative for Epstein-Barr virus nuclear antigen (EBNA) and does not express surface immunoglobulins, further distinguishing it from B-lymphocyte-derived lines. SU-DHL-1 is a hallmark model for ALK-positive ALCL due to its chromosomal translocation t(2;5)(p23;q35), which leads to the expression of the NPM1-ALK fusion protein. This fusion confers constitutive tyrosine kinase activity and plays a central role in the oncogenesis of ALK+ ALCL. The cell line is part of the LL-100 panel, a curated set of leukemia and lymphoma models for high-throughput molecular profiling. SU-DHL-1 has been extensively used in studies related to oncogenic signaling, targeted therapy development, and transcriptional regulation within ALCL, making it a key tool in the understanding and treatment of this aggressive T-cell lymphoma subtype. |
|---|---|
| Organism | Human |
| Tissue | Pleural effusion |
| Disease | Anaplastic large cell lymphoma, ALK-positive |
| Synonyms | SU-DHL1, SUDHL1, SUDHL-1, SuDHL-1, SuDHL 1, Stanford University-Diffuse Histiocytic Lymphoma-1 |
Characteristics
| Age | 10 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Lymphoblast-like |
| Cell type | Histiocytic cell |
| Growth properties | Suspension |
Regulatory Data
| Citation | SU-DHL-1 (Cytion catalog number 305876) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0538 |
Biomolecular Data
| Antigen expression | Monocyte Marker: CD163+ Lymphoid Marker: CD45- Progenitor Markers: CD10-, CD34- Activation Markers: CD30+, CD25+, CD70+, CD71+, CD80-, HLA-DR+, CD45- T-Cell Markers: CD2-, CD3-, CD4-, CD5+, CD7-, CD8- B-Cell Markers: CD19-, CD20-, CD21-, CD22- Myelomonocytic Markers: CD11b-, CD11c-, CD13-, CD14-, CD15-, CD33- |
|---|---|
| Oncogenes | C-fms (proto-oncogene); bcl-6+ (c-onc) |
| Mutational profile | Mutation: Gene fusion, ALK + HGNC, NPM1, Name(s)=NPM1-ALK (PubMed=7824924, PubMed=9121481, PubMed=25485619, PubMed=26657151, PubMed=29899875). Mutation, TP53, Simple, p.Arg273His (c.818G>A), Heterozygous (Cosmic-CLP=909742). |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | - |
| Doubling time | ~40-50 hours |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305876-071125 | Certificate of Analysis | 11. Dec. 2025 | 305876 |
-
Related products
Related products
SU-DHL-4 CellsOrganism Human Tissue Peritoneal effusion Disease Diffuse large B-cell lymphoma CAD$545.10*SU-DHL-8 CellsOrganism Human Tissue Pleural effusion Disease Diffuse large B-cell lymphoma germinal center B-cell type CAD$545.10*